Chondrosarcoma: all 99 studies

Page 1 of 1. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Clinical Applicability of Liquid Biopsy in ChondrosarcomaRecruitingNCT07492823
• Diagnostic and Therapeutic Targets in Cartilaginous TumoursRecruitingNCT07315542
• Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic SequencingRecruitingNCT06749366
• PET-imaging of Two Vartumabs in Patients With Solid TumorsRecruitingNCT06645808Early Phase 1
• A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative PlanningRecruitingNCT06387485Not applicable
• Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsRecruitingNCT06176989Phase 2
• Understanding Engagement Trends in Chondrosarcoma Clinical TrialsNot yet recruitingNCT06029478
• Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton TherapyRecruitingNCT06029218Not applicable
• Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull BaseRecruitingNCT05861245Not applicable
• Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage SurgeryRecruitingNCT05779670
• A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade ChondrosarcomaRecruitingNCT05193188Phase 2
• Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic SarcomasRecruitingNCT05131386Phase 2
• IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 1
• Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the BoneRecruitingNCT05033288
• Neutrophils in Bone SarcomasRecruitingNCT04867421
• Image Assisted Optimization of Proton Radiation Therapy in Chordomas and ChondrosarcomasRecruitingNCT04832620
• BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT04091295
• Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasRecruitingNCT04055220Not applicable
• Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationRecruitingNCT04040205Phase 2
• Assessment of Healing and Function After Reconstruction Surgery for Bone SarcomasRecruitingNCT03442465
• Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaActive, not recruitingNCT04340843Phase 2Results posted
• Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesCompletedNCT03474640Phase 1Results posted
• Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCompletedNCT02273739Phase 1/2Results posted
• Linsitinib in Treating Patients With Gastrointestinal Stromal TumorsCompletedNCT01560260Phase 2Results posted
• Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryCompletedNCT01553539Phase 2Results posted
• Proton Radiation for Chordomas and ChondrosarcomasCompletedNCT01449149Not applicableResults posted
• Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRICompletedNCT01336803Phase 2Results posted
• Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic ChondrosarcomaCompletedNCT01330966Phase 2Results posted
• Vismodegib in Treating Patients With Advanced ChondrosarcomasActive, not recruitingNCT01267955Phase 2Results posted
• Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1/2Results posted
• Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerTerminatedNCT01132547Phase 3Results posted
• Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent SarcomaCompletedNCT00949325Phase 1/2Results posted
• Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainTerminatedNCT00550654Phase 2Results posted
• Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3Results posted
• Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasCompletedNCT00474994Phase 2Results posted
• Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
• Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal CancerCompletedNCT00445965Phase 2Results posted
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent ChondrosarcomaCompletedNCT00073983Phase 2Results posted
• Clear Cell Chondrosarcoma in ItalyActive, not recruitingNCT07360964Not applicable
• Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs ResectionCompletedNCT06714773
• Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT06535997
• Periosteal Chondrosarcoma: a Single Institution ExperienceCompletedNCT05511883
• YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic SarcomaActive, not recruitingNCT05448820Phase 1/2
• Study of INBRX-109 in Conventional ChondrosarcomaActive, not recruitingNCT04950075Phase 2
• TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN LossStatus unknownNCT04690725Phase 1/2
• A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid TumorsActive, not recruitingNCT04673942Phase 2
• Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersTerminatedNCT04553692Phase 1
• Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsActive, not recruitingNCT04521686Phase 1
• AG-120 in People With IDH1 Mutant ChondrosarcomaActive, not recruitingNCT04278781Phase 2
• Apatinib for Inoperable Advanced ChondrosarcomaCompletedNCT04260113Not applicable
• Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type ChondrosarcomaWithdrawnNCT04098887Not applicable
• Long-Term Longitudinal QoL in Patients Undergoing EEAActive, not recruitingNCT04087902
• The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
• Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
• Synovial Chondrosarcoma: a Single Institution ExperienceCompletedNCT03776942
• Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasTerminatedNCT03670069Phase 1
• Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label UseCompletedNCT03491371Not applicable
• Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone SarcomasCompletedNCT03277924Phase 1/2
• Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b TrialActive, not recruitingNCT03173976Phase 1
• Low Grade Chondrosarcoma Versus EnchondromaCompletedNCT02996747
• A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial CarcinomaStatus unknownNCT02982486Phase 2
• Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of RetroperitoneumStatus unknownNCT02587169Phase 1/2
• Metformin And Chloroquine in IDH1/2-mutated Solid TumorsCompletedNCT02496741Phase 1/2
• A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasCompletedNCT02389244Phase 2
• Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 MutationCompletedNCT02073994Phase 1
• A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed ChondrosarcomasSuspendedNCT02008019Phase 2
• Autologous Dendritic Cell Vaccine in Patients With Soft Tissue SarcomaStatus unknownNCT01883518Phase 1/2
• IPI-926 Extension Protocol for Continuation of Treatment With IPI-926CompletedNCT01609179Not applicable
• High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of SkullActive, not recruitingNCT01346124Not applicable
• Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull BaseStatus unknownNCT01182753Phase 3
• A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1CompletedNCT00948961Phase 1/2
• Imatinib in Patients With Desmoid Tumor and ChondrosarcomaCompletedNCT00928525Phase 2
• Proton Therapy for Chordomas and/or ChondrosarcomasCompletedNCT00797602
• Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical SpineCompletedNCT00592748Phase 1/2
• A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)TerminatedNCT00543712Phase 2
• Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
• Proton Beam Therapy for ChondrosarcomaActive, not recruitingNCT00496522Phase 2
• Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgeryCompletedNCT00450736Phase 1
• Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1
• Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaCompletedNCT00413075Phase 1
• A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasCompletedNCT00401388Phase 2
• Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWithdrawnNCT00378781Not applicable
• Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With CancerStatus unknownNCT00349024Not applicable
• Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWithdrawnNCT00334984Not applicable
• Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaStatus unknownNCT00334854Phase 3
• Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorCompletedNCT00161187Phase 1
• Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesCompletedNCT00154388Phase 2
• S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic ChondrosarcomaCompletedNCT00107419Phase 2
• S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the BoneCompletedNCT00096213Phase 2
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
• Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
• Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsCompletedNCT00025441Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2
• Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaCompletedNCT00003308Phase 2
• S9624 Ifosfamide in Treating Patients With Meningeal TumorsTerminatedNCT00003292Phase 2
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerCompletedNCT00002515Phase 2

← Chondrosarcoma overview